Latest Breaking News On - Psilocybin therapy - Page 5 : comparemela.com

California Senate Passes Amended Psychedelics Legalization Bill

The California state Senate on Thursday gave its final approval to a bill to legalize certain naturally occurring psychedelics including "magic mushrooms."

United statesSan franciscoGavin newsomScott wienerMental healthHuman services agencyPsychedelics policy study groupAssembly onCalifornia healthSenate billSan francisco democrat scott wienerCalifornia senateState assemblyMarijuana momentCalifornia senate bill 58California sb 58

Psilocybin Plus Therapy Can Help Treat Depression Symptoms, Study Finds

The researchers found a single dose of psilocybin combined with therapy seemed to produce a "rapid and sustained antidepressant effect" for up to six weeks.

Treatment resistant depressionMajor depressive disorderManagement of depressionPsilocybin therapyLegal status of psilocybin mushroomsPsilocybin mushroom

atai Life Sciences (ATAI) Reports Q2, Announces Clinical Data from the Phase 1 Study of DMX-1002

atai Life Sciences (ATAI) Reports Q2, Announces Clinical Data from the Phase 1 Study of DMX-1002
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSrinivas raoMarek malikHercules capital incAmerican medical associationLife sciencesDevelopment rd expensesImperial collegeExchange commissionFlorian brandOpioid use disorderProfessor emeritusCardiac electrophysiologyProgram update

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesSrinivas raoMarek malikDevelopment rd expensesExchange commissionLife sciencesHercules capital incAmerican medical associationImperial collegeCognitive impairment associatedOpioid useFlorian brandOpioid use disorderProfessor emeritus

Atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients with Cognitive Impairment Associated with SchizophreniaDMX-1002 Phase 1 results. -Today at 07:04 am- MarketScreener

City ofUnited kingdomUnited statesSrinivas raoMarek malikLife sciencesHercules capital incExchange commissionDevelopment rd expensesImperial collegeAmerican medical associationCognitive impairment associatedOpioid useFlorian brandOpioid use disorderProfessor emeritus